SCREW, FIXATION, BONE
Report
- Report Number
- 2939274-2019-56587
- Event Type
- Injury
- Date Received
- February 21, 2019
- Report Date
- January 28, 2019
- Manufacturer
- WRIGHTS LANE SYNTHES USA PRODUCTS LLC
- Product Code
- HWC
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
510K: THIS REPORT IS FOR UNKNOWN SCREWS/UNKNOWN LOT. PART AND LOT NUMBER ARE UNKNOWN; UDI NUMBER IS UNKNOWN. COMPLAINANT PART IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. PRODUCT WAS NOT RETURNED. BASED ON THE INFORMATION AVAILABLE, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND/OR PREVENTATIVE ACTION IS PROPOSED. THIS COMPLAINT WILL BE ACCOUNTED FOR AND MONITORED VIA POST MARKET SURVEILLANCE ACTIVITIES. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. [(B)(4)].
THIS REPORT IS BEING FILED AFTER THE REVIEW OF THE FOLLOWING JOURNAL ARTICLE: C. ONG ET AL (2012). OUTCOMES OF OPEN REDUCTION AND INTERNAL FIXATION OF PROXIMAL HUMERUS FRACTURES MANAGED WITH LOCKING PLATES. THE AMERICAN JOURNAL OF ORTHOPEDICS. PAGE 407-412. (USA). THE PURPOSE OF THIS STUDY IS TO EVALUATE THE OUTCOMES AND COMPLICATIONS OF OPEN REDUCTION AND INTERNAL FIXATION (ORIF) OF 2-, 3-, AND 4-PART PROXIMAL HUMERUS FRACTURES USING A STANDARD MANAGEMENT PROTOCOL WITH LOCKING PLATES. FROM FEBRUARY 2003 TO JANUARY 2008, 63 PATIENTS WITH ACUTE PROXIMAL HUMERUS FRACTURES MANAGED WITH ORIF AND LOCKING PLATES WERE INCLUDED IN THIS STUDY. SIXTY-THREE ACUTE FRACTURES WERE IDENTIFIED IN 63 ADULTS (19 MEN, 44 WOMEN) MEAN AGE WAS 62 YEARS AND MEAN FOLLOW-UP WAS 19 MONTHS. THERE WERE 12 TWO-PART FRACTURES, 42 THREE-PART FRACTURES, AND 9 FOUR-PART FRACTURES. PROXIMAL HUMERUS LOCKING PLATE (SYNTHES, PAOLI, PENNSYLVANIA) WAS USED TO TREAT THE FRACTURES. PATIENTS WERE EVALUATED 1, 6, 12, 26, AND 52 WEEKS AFTER SURGERY. PATIENTS WERE FOLLOWED FOR A MINIMUM OF 12 MONTHS; WHEN CLINICALLY INDICATED, FOLLOW-UP WAS CONTINUED BEYOND 12 MONTHS. MEAN FOLLOW-UP FOR THE COHORT WAS 19 MONTHS (RANGE, 12-64 MONTHS). THE COMPLICATIONS WERE REPORTED AS FOLLOWS: SEVEN PATIENTS HAD SCREWS THAT PENETRATED THE HUMERAL HEAD. FIVE OF THE 7 HAD THESE SCREWS REMOVED (ROM AND SYMPTOMS IMPROVED SIGNIFICANTLY); THE OTHER 2 WERE ASYMPTOMATIC AND DID NOT REQUIRE HARDWARE REMOVAL. THIS REPORT IS FOR UNKNOWN SCREWS. THIS IS REPORT 10 OF 10 FOR (B)(4). ADDITIONAL COMPLICATIONS ARE CAPTURED ON RELATED COMPLAINTS (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 153467 | SCREW, FIXATION, BONE | HWC | WRIGHTS LANE SYNTHES USA PRODUCTS LLC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |